Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.

Between August 1989 and November 2003, 33 patients at our center with acquired aplastic anemia underwent bone marrow transplantation (BMT) from HLA-identical sibling donors with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies (MoAb) for conditioning. The median age at BMT was 17 years (...

Descrición completa

Detalles Bibliográficos
Main Authors: Gupta, V, Ball, SE, Yi, Q, Sage, D, McCann, SR, Lawler, M, Ortin, M, Freires, M, Hale, G, Waldmann, H, Gordon-Smith, E, Marsh, J
Formato: Journal article
Idioma:English
Publicado: 2004